199 related articles for article (PubMed ID: 23077602)
1. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.
Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
PLoS One; 2012; 7(10):e47365. PubMed ID: 23077602
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Aljapawe A; Ikhtiar A
Cancer Biomark; 2017 Sep; 20(3):333-343. PubMed ID: 28800312
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.
Reynés G; Vila V; Fleitas T; Reganon E; Font de Mora J; Jordá M; Martínez-Sales V
PLoS One; 2013; 8(7):e69034. PubMed ID: 23922679
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Japawe A; Ikhtiar A
Lung Cancer; 2018 Oct; 124():23-30. PubMed ID: 30268466
[TBL] [Abstract][Full Text] [Related]
5. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles.
Liu T; Wang J; Li T; Cui P; Hou B; Zhuang C; Wei G; Zhang S; Li H; Hu Y
BMC Cancer; 2021 Aug; 21(1):939. PubMed ID: 34416874
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer.
Wang CC; Tseng CC; Hsiao CC; Chang HC; Chang LT; Fang WF; Leu S; Wang YH; Tsai TH; Yang CT; Chen CH; Yip HK; Ho CK; Lin MC
Biomed Res Int; 2014; 2014():173401. PubMed ID: 25061601
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
[TBL] [Abstract][Full Text] [Related]
9. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the Therapeutic Effects of Pembrolizumab and Nivolumab in Advanced Non-Small Cell Lung Cancer by Platelet-Derived Microparticles in Circulating Blood.
Liu T; Wang J; Liu Y; Wu J; Yuan Y; Wang C; Fang X; Li H
Technol Cancer Res Treat; 2021; 20():1533033821997817. PubMed ID: 33612078
[TBL] [Abstract][Full Text] [Related]
11. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Nicolazzo C; Raimondi C; Loreni F; Gazzaniga P; Gradilone A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629196
[TBL] [Abstract][Full Text] [Related]
13. Levels of circulating microparticles in lung cancer patients and possible prognostic value.
Tseng CC; Wang CC; Chang HC; Tsai TH; Chang LT; Huang KT; Leu S; Yen CH; Liu SF; Chen CH; Yang CT; Yip HK; Lin MC
Dis Markers; 2013; 35(5):301-10. PubMed ID: 24167378
[TBL] [Abstract][Full Text] [Related]
14. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Alama A; Coco S; Vanni I; Grossi F
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629197
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients.
Arrieta O; Pineda B; Muñiz-Hernández S; Flores D; Ordóñez G; Borbolla-Escoboza JR; Orta D
Cancer Biomark; 2014; 14(4):215-23. PubMed ID: 24934364
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
17. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
[TBL] [Abstract][Full Text] [Related]
18. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial cells as a biomarker in non-small cell lung cancer patients: correlation with clinical outcome.
Najjar F; Alammar M; Bachour M; Al-Massarani G
Int J Biol Markers; 2014 Dec; 29(4):e337-44. PubMed ID: 25041783
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]